Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization
Abstract No licensed human vaccines are currently available against leishmaniasis. Several anti-leishmanial vaccines are currently undergoing testing, including genetically modified live-attenuated parasite vaccines. Studies with live attenuated Leishmania vaccines such as centrin deleted Leishmania...
Enregistré dans:
Auteurs principaux: | Sreenivas Gannavaram, John Torcivia, Lusine Gasparyan, Amit Kaul, Nevien Ismail, Vahan Simonyan, Hira L. Nakhasi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d976c0ed5ec047e4a8b50c73f5058f1b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
par: Wen-Wei Zhang, et autres
Publié: (2020) -
Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis
par: Subir Karmakar, et autres
Publié: (2021) -
Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice
par: Guilherme D. Melo, et autres
Publié: (2017) -
Identification of a secreted casein kinase 1 in Leishmania donovani: effect of protein over expression on parasite growth and virulence.
par: Mary Dan-Goor, et autres
Publié: (2013) -
Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis.
par: Doumet Georges Helou, et autres
Publié: (2021)